Brief: Palisade Bio Cleared By Health Canada To Commence Phase 1 Clinical Study
Oct 10 (Reuters) - Palisade Bio Inc PALI.O :
* PALISADE BIO CLEARED BY HEALTH CANADA TO COMMENCE PHASE 1
CLINICAL STUDY FOR LEAD PROGRAM, PALI-2108 FOR THE TREATMENT OF
ULCERATIVE COLITIS (UC)
* PALISADE BIO INC - ON TRACK COMMENCE SITE INITIATION AND
ENROLLMENT FOR STUDY BEFORE YEAR END
Source text for Eikon: ID:nGNXzDPDc
Further company coverage: PALI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing